• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Not Very Marvell-ous Charts

Tech company MRVL gets quantitative downgrade and has weakening charts.
By BRUCE KAMICH
Mar 04, 2021 | 01:02 PM EST
Stocks quotes in this article: MRVL

We have commented on the charts of Marvell Technology Group (MRVL) which just reported Wednesday night, a number of times in the past. Our last review was Nov. 30 when we wrote that " With the shares reaching our $46 price target and a number of bearish divergences grabbing our attention ahead of earnings on Thursday I would recommend booking profits here and standing aside until we see how the stock reacts on Friday."

Prices traded up into late January but the signals have turned from bullish to bearish. 

Let's view the charts again now that TheStreet's quantitative service downgraded the stock to hold. 
 
In this daily bar chart of MRVL, below, we can see that prices failed to make a new high in February and then turned low. Prices have broken below the cresting 50-day moving average line and are testing the rising 200-day moving average line. The On-Balance-Volume (OBV) line made a peak in January and has been moving lower telling us that traders have shifted from aggressive buying to aggressive selling. The Moving Average Convergence Divergence (MACD) oscillator just broke below the zero-line for an outright-sell signal. 
 
 
 
In this weekly bar chart of MRVL, below, we can see a weakening picture. Prices are testing the rising 40-week moving average line. The weekly OBV line shows weakness from the middle of February. The MACD oscillator just crossed to the downside for a take-profit sell signal. 
 
 
In this daily Point and Figure chart of MRVL, below, we can see a potential downside price target in the $33 area.  
 
 
Bottom line strategy: A quantitative downgrade on top of weakening charts is not a good combination. Continue to avoid the long side of MRVL, until a new bottom pattern develops. 

(Marvell Technology is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells MRVL? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Technology | Technology Hardware & Equipment | Quant Ratings

More from Stocks

Amid Dreary Trading, a Slim Glimmer of Hope

James "Rev Shark" DePorre
Sep 27, 2023 4:30 PM EDT

Meta swings midday and the bulls lose footing, but the small caps were a bright spot.

NextEra Energy Is Suffering Through a Power Outage

Bruce Kamich
Sep 27, 2023 2:24 PM EDT

What do the charts suggest for price targets?

Here's Why Buyers May Want to Hold Off for a Bit

James "Rev Shark" DePorre
Sep 27, 2023 11:30 AM EDT

The chance of a government shutdown is keeping traders on the sidelines right now.

Anxiety Creeps Back Into the Markets, but I Think Outright Panic Could Lie Ahead

Bret Jensen
Sep 27, 2023 11:00 AM EDT

Volatility is picking up, but I believe it could become much more intense in the first half of next year.

Insulet Stock Begins to Show Signs of Life

Bruce Kamich
Sep 27, 2023 10:20 AM EDT

Let's see if the charts of this medical device maker are now attractive.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:43 AM EDT BRUCE KAMICH

    Bob Farrell's 10 Rules of Investing

    I always take a hard copy book to read when I trav...
  • 12:20 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Trading in Multiple Time Frames
  • 10:24 AM EDT BRUCE KAMICH

    This Could Get Messy

    A number of key stocks are getting close to import...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login